Adjunct ketamine treatment effects on treatment-resistant depressive symptoms in chronic treatment-resistant schizophrenia patients are short-term and disassociated from regional homogeneity changes in key brain regions – a pilot study

Adjunct ketamine treatment effects on treatment-resistant depressive symptoms in chronic treatment-resistant schizophrenia patients are short-term and disassociated from regional homogeneity changes in key brain regions – a pilot study

BACKGROUND: To investigate the effects of adjunct ketamine treatment on depressive symptoms and brain activity in chronic treatment-resistant schizophrenia (CTRS) patients with treatment-resistant depressive (TRD) symptoms. METHODS: Calgary Depression Scale for Schizophrenia (CDSS), positive and neg...

Full description

Bibliographic Details
Main Authors: Jiaen Ye, Xiaodong Lin, Deguo Jiang, Min Chen, Yanchi Zhang, Hongjun Tian, Jie Li, Chuanjun Zhuo, Yanling Zhao
Format: Article
Language:English
Published: AVES 2019-10-01
Series:Psychiatry and Clinical Psychopharmacology
Subjects:
ketamine
depressive symptoms
schizophrenia
fmri
reho
Online Access:http://dx.doi.org/10.1080/24750573.2019.1699726

Internet

http://dx.doi.org/10.1080/24750573.2019.1699726

Similar Items